Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris|September 18, 2003
[Otogenic cavernous sinus thrombophlebitis. A case report]E Babin, M Ndyaye, A Bequignon, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|December 7, 2025
Factors for pain in office-based voice implant replacement. A multicenter prospective GETTEC studyM André, D Culié, O Malard, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|April 21, 2019
Platinum rechallenge in recurrent head and neck squamous cell carcinoma after primary chemoradiationA Rambeau, I Licaj, B Gery, et al.
The Journal of Laryngology and Otology|March 11, 2006
Small cell neuroendocrine carcinoma of the nasal cavity and paranasal sinusesE Babin, V Rouleau, P O Vedrine, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 24, 2023
Sexual health at 5 years after diagnosis of head and neck cancerM Humbert, J Lequesne, I Licaj, et al.
Revue De Stomatologie Et De Chirurgie Maxillo-Faciale|November 18, 2005
[Detection of the sentinal node in squamous-cell carcinoma of the oral cavity and oropharynx. Preliminary study]H Bénateau, E Babin, E Soubeyrand, et al.
Oral Oncology|May 22, 2019
Impact of locoregional irradiation in patients with upfront metastatic head and neck squamous cell carcinomaA Rambeau, V Bastit, S Thureau, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|April 21, 2020
French consensus regarding precautions during tracheostomy and post-tracheostomy care in the context of COVID-19 pandemicP Schultz, J-B Morvan, N Fakhry, et al.
Life Sciences|January 1, 1994
Identification of a human delta opioid receptor: cloning and expressionR J Knapp, E Malatynska, L Fang, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 8, 2018
[Advances in the management of cervical lymphadenopathies of unknown primary with intensity modulated radiotherapy: Doses and target volumes]I Troussier, G Klausner, E Blais, et al.
Pageof 15